INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2009

In humans, circulating FGF21 was not induced by starvation or ketosis but increased following treatment with PPAR alpha and PPAR delta agonists.

Researchers evaluated plasma FGF21 during a 48-hour fast and 24-hour refeeding in 8 healthy males, a 3-month low-carbohydrate ketogenic diet in 7 obese individuals, and a 2-week treatment with PPAR agonists in 22 overweight or obese males. There was no significant variation in plasma FGF21 during fasting and refeeding, while a 3-month ketogenic diet was associated with a 42% decline in plasma FGF21 levels. Circulating FGF21 increased significantly after treatment with PPAR alpha (39%) and PPAR delta (32%) agonists, but not with a PPAR gamma agonist.

Study type
Prospective intervention study across three patient groups
Who was studied
8 healthy males (starvation), 7 obese adults (ketogenic diet), and 22 overweight/obese males (PPAR agonist treatment)
What was measured
Fasting plasma FGF21 and serum 3-hydroxybutyrate levels

THE PAPER

Circulating fibroblast growth factor 21 is induced by peroxisome proliferator-activated receptor agonists but not ketosis in man.

Christodoulides C, Dyson P, Sprecher D, Tsintzas K, Karpe F. J Clin Endocrinol Metab, 2009.

PubMed 19531592 ↗DOI 10.1210/jc.2009-0111 ↗

Nutrients & adequacyWeight & appetiteOther health

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.